Treatment of leukemia by marrow transplantation from HLA incompatible donors. Effect of HLA-disparity on GVHD, relapse and survival.
Hansen
J A
JA
Fred Hutchinson Cancer Research Center, Seattle, WA.
Anasetti
C
C
Beatty
P G
PG
Martin
P J
PJ
Sanders
J E
JE
Storb
R
R
Thomas
E D
ED
D016026:Bone Marrow Transplantation / Q000009:adverse effects / Q000276:immunology*; D003131:Combined Modality Therapy; D003524:Cyclosporins / Q000494:pharmacology; D006086:Graft vs Host Disease / Q000209:etiology* / Q000276:immunology / Q000517:prevention & control; D006680:HLA Antigens; D006801:Humans; D007938:Leukemia / Q000188:drug therapy / Q000276:immunology / Q000601:surgery*; D008727:Methotrexate / Q000494:pharmacology; D011379:Prognosis
D003524:Cyclosporins; D006680:HLA Antigens; D008727:Methotrexate